Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
Conrad V. Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Molecules (2018) Vol. 23, Iss. 3, pp. 566-566
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
Martin Marek, T.B. Shaik, Tino Heimburg, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 10000-10016
Open Access | Times Cited: 103
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina, Conrad V. Simoben, Lucas Praetorius, et al.
ChemMedChem (2021) Vol. 16, Iss. 9, pp. 1336-1359
Closed Access | Times Cited: 84
5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2
Felicite Majoumo‐Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho, et al.
Chemical Papers (2024) Vol. 78, Iss. 6, pp. 3431-3441
Open Access | Times Cited: 8
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Dušan Ružić, Nemanja Djoković, Tatjana Srdić‐Rajić, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 209-209
Open Access | Times Cited: 37
Therapeutic efficacy of Clompanus pubescens leaves fractions via downregulation of neuronal cholinesterases/Na+-K+ATPase/IL-1 β, and improving the neurocognitive and antioxidants status of streptozotocin-induced diabetic rats
Sunday Amos Onikanni, Bashir Lawal, Babatunji Emmanuel Oyinloye, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112730-112730
Open Access | Times Cited: 29
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)
Rossella Fioravanti, Nicola Mautone, Annarita Rovere, et al.
Current Opinion in Chemical Biology (2020) Vol. 57, pp. 65-74
Closed Access | Times Cited: 47
Pharmacoinformatic Investigation of Medicinal Plants from East Africa
Conrad V. Simoben, Ammar Qaseem, Aurélien F. A. Moumbock, et al.
Molecular Informatics (2020) Vol. 39, Iss. 11
Open Access | Times Cited: 45
Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding
Cyril T. Namba-Nzanguim, Conrad V. Simoben, Boris D. Bekono, et al.
The Microbe (2024) Vol. 3, pp. 100059-100059
Open Access | Times Cited: 5
Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights
Ekta Pardhi, Devendra Singh Tomar, Rahul Khemchandani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-30
Closed Access | Times Cited: 4
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
Gustavo Salgado Pires, Heber Victor Tolomeu, Daniel A. Rodrigues, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 577-577
Open Access
Computational and Preclinical Prediction of the Antimicrobial Properties of an Agent Isolated from Monodora myristica: A Novel DNA Gyrase Inhibitor
Sunday Amos Onikanni, Bashir Lawal, Adewale Oluwaseun Fadaka, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1593-1593
Open Access | Times Cited: 10
Computational Insights into Natural Antischistosomal Metabolites as SmHDAC8 Inhibitors: Molecular Docking, ADMET Profiling, and Molecular Dynamics Simulation
Abdulrahim A. Alzain, Rua M. Mukhtar, Nihal Abdelmoniem, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 658-658
Open Access | Times Cited: 9
Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
Donya Naz Divsalar, Conrad V. Simoben, Cole Schonhofer, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 27
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
Fulvio Saccoccia, Margherita Brindisi, Roberto Gimmelli, et al.
ACS Infectious Diseases (2019) Vol. 6, Iss. 1, pp. 100-113
Closed Access | Times Cited: 26
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
Ehab Ghazy, Mohamed Abdelsalam, Dina Robaa, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 15
Structure–Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma mansoni (SmSirt2)
Daria Monaldi, Dante Rotili, Julien Lancelot, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 19, pp. 8733-8759
Open Access | Times Cited: 22
Binding Free Energy (BFE) Calculations and Quantitative Structure–Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors
Conrad V. Simoben, Ehab Ghazy, Patrik Zeyen, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2584-2584
Open Access | Times Cited: 17
Therapeutic Potential of Natural Products in the Treatment of Schistosomiasis
Carine Machado Azevedo, Cássio Santana Meira, Jaqueline Silva, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6807-6807
Open Access | Times Cited: 6
Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni
Vitor Coutinho Carneiro, Isabel Caetano de Abreu da Silva, Murilo Sena Amaral, et al.
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 7, pp. e0008332-e0008332
Open Access | Times Cited: 17
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
Godwin Akpeko Dziwornu, Henrietta Dede Attram, Samuel Gachuhi, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 4, pp. 455-490
Open Access | Times Cited: 16
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis
Ehab Ghazy, Tino Heimburg, Julien Lancelot, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113745-113745
Open Access | Times Cited: 14
Alkaloids with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling
Smith B. Babiaka, Conrad V. Simoben, Kennedy O. Abuga, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 70-70
Open Access | Times Cited: 13
Best Practices for Docking-Based Virtual Screening
Bruno J. Neves, Melina Mottin, José Teófilo Moreira-Filho, et al.
Elsevier eBooks (2021), pp. 75-98
Closed Access | Times Cited: 12
Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues
Bartosz Bieszczad, Damian Garbicz, Marta Świtalska, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 851-851
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top